Xie J., Yang Y., Gao Y., He J. Cuproptosis: Mechanisms And Links With Cancers. Mol Cancer. 2023;22(1):46. DOI: 10.1186/S12943-023-01732-Y..
DOI: 10.1186/S12943-023-01732-Y

Costello L.C., Franklin R.B. Zinc Is Decreased In Prostate Cancer: An Established Relationship Of Prostate Cancer! J Biol Inorg Chem. 2011;16(1):3-8. DOI: 10.1007/S00775-010-0736-9..
DOI: 10.1007/S00775-010-0736-9

Yaman M., Kaya G., Simsek M.Comparison Of Trace Element Concentrations In Cancerous And Noncancerous Human Endometrial And Ovary Tissues.Int J Gynecol Cancer. 2007;17(1):220-228. DOI: 10.1111/J.1525-1438.2006.00742.X..
DOI: 10.1111/J.1525-1438.2006.00742.X

Krizkova S., Ryvolova M., Hrabeta J., Adam V., Stiborova M., Eckschlager T., Kizek R. Metallothioneins And Zinc In Cancer Diagnosis And Therapy. Drug Metab Rev. 2012;44(4):287-301. DOI: 10.3109/03602532.2012.725414..
DOI: 10.3109/03602532.2012.725414

Li Y. Copper Homeostasis: Emerging Target For Cancer Treatment. IUBMB Life. 2020;72(9):1900-1908. DOI: 10.1002/Iub.2341..
DOI: 10.1002/Iub.2341

Hammond E.M., Giaccia, A.J. The role of p53 in hypoxia-induced apoptosis. biochemical and biophysical research communications. 2005;331(3):718-725. DOI:10.1016/J.Bbrc.2005.03.154.
DOI: 10.1016/J.Bbrc.2005.03.154

Feng Y., Zeng J.W., Ma Q., Zhang S., Tang J., Feng J.F. Serum copper and zinc levels in breast cancer: a meta-analysis. J Trace Elem Med Biol. 2020;62:126629. DOI: 10.1016/J.Jtemb.2020.126629..
DOI: 10.1016/J.Jtemb.2020.126629

Saleh S.A.K., Adly H.M., Abdelkhaliq A.A., NassirA.M. Serum Levels Of Selenium, Zinc, Copper, Manganese, And Iron In Prostate Cancer Patients. Curr Urol. 2020;14(1):44-49. DOI: 10.1159/000499261..
DOI: 10.1159/000499261

Zhang M., Shi M., Zhao Y. Association Between Serum Copper Levels And Cervical Cancer Risk: A Meta-Analysis. Biosci Rep. 2018;38(4):BSR20180161. DOI: 10.1042/BSR20180161..
DOI: 10.1042/BSR20180161

Mazdak H., Yazdekhasti F., Movahedian A., Mirkheshti N., Shafieian M. The Comparative Study Of Serum Iron, Copper, And Zinc Levels Between Bladder Cancer Patients And A Control Group.Int Urol Nephrol. 2010;42(1):89-93. DOI: 10.1007/S11255-009-9583-4..
DOI: 10.1007/S11255-009-9583-4

Baltaci A.K., Dundar T.K., Aksoy F., Mogulkoc R. Changes In The Serum Levels Of Trace Elements Before And After The Operation In Thyroid Cancer Patients. Biol Trace Elem Res. 2017;175(1):57-64. DOI: 10.1007/S12011-016-0768-2..
DOI: 10.1007/S12011-016-0768-2

Baharvand M., Manifar S., Akkafan R., Mortazavi H., Sabour S. Serum Levels Of Ferritin, Copper, And Zinc In Patients With Oral Cancer. Biomed J. 2014;37(5):331-336. DOI: 10.4103/2319-4170.132888..
DOI: 10.4103/2319-4170.132888

Gomez M.L., Shah N., Kenny T.C., Jenkins E.C. Jr, Germain D. SOD1 Is Essential For Oncogene-Driven Mammary Tumor Formation But Dispensable For Normal Development And Proliferation. Oncogene. 2019 Jul;38(29):5751-5765. DOI: 10.1038/S41388-019-0839-X..
DOI: 10.1038/S41388-019-0839-X

Blockhuys S., Brady D.C., Wittung-Stafshede P. Evaluation Of Copper Chaperone ATOX1 As Prognostic Biomarker In Breast Cancer. Breast Cancer. 2020;27(3):505-509. DOI: 10.1007/S12282-019-01044-4..
DOI: 10.1007/S12282-019-01044-4

Zhang X., Walke G.R., Horvath I., Kumar R., Blockhuys S., Holgersson S., Walton P.H., Wittung-Stafshede P. Memo1 Binds Reduced Copper Ions, Interacts With Copper Chaperone Atox1, And Protects Against Copper-Mediated Redox Activity In Vitro. Proc Natl Acad Sci U S A. 2022;119(37):E2206905119. DOI: 10.1073/Pnas.2206905119..
DOI: 10.1073/Pnas.2206905119

Tsymbal S.A., Refeld A.G., Kuchur O.A. The P53 Tumor Suppressor And Copper Metabolism: An Unrevealed But Important Link. Mol Biol (Mosk). 2022;56(6):1057-1071. DOI: 10.31857/S0026898422060222..
DOI: 10.31857/S0026898422060222

Tsymbal S.A., Refeld A.G., Kuchur O.A. The P53 Tumor Suppressor And Copper Metabolism: An Unrevealed But Important Link. Mol Biol (Mosk). 2022;56(6):1057-1071. DOI: 10.31857/S0026898422060222..
DOI: 10.31857/S0026898422060222

Wang W., Lu K., Jiang X., Wei Q., Zhu L., Wang X., Jin H., Feng L. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res. 2023;42(1):142. DOI: 10.1186/s13046-023-02720-2..
DOI: 10.1186/s13046-023-02720-2

Brady D.C., Crowe M.S., Greenberg D.N., Counter C.M. Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis And Counters Resistance To BRAFV600E And MEK1/2 Inhibitors. Cancer Res. 2017;77(22):6240-6252. DOI: 10.1158/0008-5472.CAN-16-1190..
DOI: 10.1158/0008-5472.CAN-16-1190

Samimi G., Varki N.M., Wilczynski S., Safaei R., Alberts D.S., Howell S.B. Increase In Expression Of The Copper Transporter ATP7A During Platinum Drug-Based Treatment Is Associated With Poor Survival In Ovarian Cancer Patients. Clin Cancer Res. 2003;9(16 Pt 1):5853-5859.

Chang A. Chemotherapy, Chemoresistance And The Changing Treatment Landscape For NSCLC. Lung Cancer. 2011;71(1):3-10. DOI: 10.1016/J.Lungcan.2010.08.022.
DOI: 10.1016/J.Lungcan.2010.08.022

Kanzaki A., Toi M., Neamati N., Miyashita H., Oubu M., Nakayama K., Bando H., Ogawa K., et al. Copper-Transporting P-Type Adenosine Triphosphatase (ATP7B) Is Expressed In Human Breast Carcinoma. Jpn J Cancer Res. 2002;93(1):70-77. DOI: 10.1111/j.1349-7006.2002.tb01202.x..
DOI: 10.1111/j.1349-7006.2002.tb01202.x

Miyashita H., Nitta Y., Mori S., Kanzaki A., Nakayama K., Terada K., Sugiyama T., et al. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. Oral Oncol. 2003;39(2):157-162. DOI: 10.1016/s1368-8375(02)00038-6..
DOI: 10.1016/s1368-8375(02)00038-6

Ohbu M., Ogawa K., Konno S., Kanzaki A., Terada K., Sugiyama T., Takebayashi Y. Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma. Cancer Lett. 2003;189(1):33-38. DOI: 10.1016/s0304-3835(02)00462-7..
DOI: 10.1016/s0304-3835(02)00462-7

Tadini-Buoninsegni F., Bartolommei G., Moncelli M.R., Inesi G., Galliani A., Sinisi M., Losacco M., Natile G., et al. Translocation Of Platinum Anticancer Drugs By Human Copper Atpases ATP7A And ATP7B. Angew Chem Int Ed Engl. 2014;53(5): 1297-1301. DOI: 10.1002/Anie.201307718..
DOI: 10.1002/Anie.201307718

Song I.S., Savaraj N., Siddik Z.H., Liu P., Wei Y., Wu C.J., Kuo M.T. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther. 2004;3(12):1543-1539.

Chen H.H., Yan J.J., Chen W.C., Kuo M.T., Lai Y.H., Lai W.W., Liu H.S., Su W.C. Predictive And Prognostic Value Of Human Copper Transporter 1 (Hctr1) In Patients With Stage III Non-Small-Cell Lung Cancer Receiving First-Line Platinum-Based Doublet Chemotherapy. Lung Cancer. 2012;75(2):228-234. DOI: 10.1016/J.Lungcan.2011.06.011..
DOI: 10.1016/J.Lungcan.2011.06.011

Bendellaa M., Lelièvre P., Coll J.L., Sancey L., Deniaud A., Busser B. Roles Of Zinc In Cancers: From Altered Metabolism To Therapeutic Applications.Int J Cancer. 2024;154(1):7-20. DOI: 10.1002/Ijc.34679..
DOI: 10.1002/Ijc.34679

Kambe T., Tsuji T., Hashimoto A., Itsumura N. The Physiological, Biochemical, And Molecular Roles Of Zinc Transporters In Zinc Homeostasis And Metabolism. Physiol Rev. 2015;95(3):749-784. DOI: 10.1152/Physrev.00035.2014..
DOI: 10.1152/Physrev.00035.2014

Pan Z., Choi S., Ouadid-Ahidouch H., Yang J.M., Beattie J.H., Korichneva I. Zinc Transporters And Dysregulated Channels In Cancers. Front Biosci (Landmark Ed). 2017;22(4):623-643. DOI: 10.2741/4507..
DOI: 10.2741/4507

Братчиков О.И., Дубонос П.А., Тюзиков И.А., Жиляева Ю.А. Современные возможности повышения эффективности комплексной фармакотерапии хронического бактериального простатита. Урология. 2022;(3):76-82. DOI: 10.18565/Urology.2022.3.76-82. EDN: KPSLEM..
DOI: 10.18565/Urology.2022.3.76-82. EDN: KPSLEM

Ziliotto S., Gee J.M.W., Ellis I.O., Green A.R., Finlay P., Gobbato A., Taylor K.M. Activated Zinc Transporter ZIP7 As An Indicator Of Anti-Hormone Resistance In Breast Cancer. Metallomics. 2019;11(9):1579-1592. DOI: 10.1039/C9mt00136k..
DOI: 10.1039/C9mt00136k

Takatani-Nakase T. Zinc Transporters And The Progression Of Breast Cancers. Biol Pharm Bull. 2018;41(10):1517-1522. DOI: 10.1248/Bpb.B18-00086..
DOI: 10.1248/Bpb.B18-00086

Brethour D., Mehrabian M., Williams D., Wang X., Ghodrati F., Ehsani S., Rubie E.A., Woodgett J.R., et al. A ZIP6-ZIP10 Heteromer Controls NCAM1 Phosphorylation And Integration Into Focal Adhesion Complexes During Epithelial-To-Mesenchymal Transition. Sci Rep. 2017;7:40313. DOI: 10.1038/Srep40313..
DOI: 10.1038/Srep40313

Bai Y., Wang G., Fu W., Lu Y., Wei W., Chen W., Wu X., Meng H., et al. Circulating Essential Metals And Lung Cancer: Risk Assessment And Potential Molecular Effects. Environ Int. 2019;127:685-693. DOI: 10.1016/J.Envint.2019.04.021..
DOI: 10.1016/J.Envint.2019.04.021

Cheng X., Wei L., Huang X., Zheng J., Shao M., Feng T., Li J., Han Y., et al. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness Of Esophageal Carcinoma Cells By Increasing Intracellular Levels Of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, And Up-Regulating Genes That Regulate Metastasis. Gastroenterology. 2017;152(8):1985-1997.E12. DOI: 10.1053/J.Gastro.2017.02.006..
DOI: 10.1053/J.Gastro.2017.02.006

Ishida S., Kasamatsu A., Endo-Sakamoto Y., Nakashima D., Koide N., Takahara T., Shimizu T., Iyoda M., et al. Novel Mechanism Of Aberrant ZIP4 Expression With Zinc Supplementation In Oral Tumorigenesis. Biochem Biophys Res Commun. 2017;483(1):339-345. DOI: 10.1016/J.Bbrc.2016.12.142..
DOI: 10.1016/J.Bbrc.2016.12.142

Pal D., Sharma U., Singh S.K., Prasad R. Association Between ZIP10 Gene Expression And Tumor Aggressiveness In Renal Cell Carcinoma. Gene. 2014;552(1):195-198. DOI: 10.1016/J.Gene.2014.09.010..
DOI: 10.1016/J.Gene.2014.09.010

Ribeiro S.M.F., Braga C.B.M., Peria F.M., Martinez E.Z., Rocha J.J.R.D., Cunha S.F.C. Effects Of Zinc Supplementation On Fatigue And Quality Of Life In Patients With Colorectal Cancer. Einstein (Sao Paulo).2017;15(1):24-28. DOI: 10.1590/S1679-45082017AO3830..
DOI: 10.1590/S1679-45082017AO3830

Denoyer D., Clatworthy S.A.S., Cater M.A. Copper Complexes In Cancer Therapy. Met Ions Life Sci. 2018;18:/Books/9783110470734/9783110470734-022/9783110470734-022.Xml. DOI: 10.1515/9783110470734-022..
DOI: 10.1515/9783110470734-022

Brewer G.J., Dick R.D., Grover D.K., Leclaire V., Tseng M., Wicha M., Pienta K., Redman B.G., et al. Treatment Of Metastatic Cancer With Tetrathiomolybdate, An Anticopper, Antiangiogenic Agent: Phase I Study. Clin Cancer Res. 2000;6(1):1-10.

Wadhwa S., Mumper R.J. D-Penicillamine And Other Low Molecular Weight Thiols: Review Of Anticancer Effects And Related Mechanisms. Cancer Lett. 2013;337(1):8-21. DOI: 10.1016/J.Canlet.2013.05.027..
DOI: 10.1016/J.Canlet.2013.05.027

Kathawala M., Hirschfield G.M. Insights Into The Management Of Wilson's Disease. Therap Adv Gastroenterol. 2017;10(11):889-905. DOI: 10.1177/1756283X17731520..
DOI: 10.1177/1756283X17731520

Cater M.A., Haupt Y. Clioquinol Induces Cytoplasmic Clearance Of The X-Linked Inhibitor Of Apoptosis Protein (XIAP): Therapeutic Indication For Prostate Cancer. Biochem J. 2011;436(2):481-491. DOI: 10.1042/BJ20110123..
DOI: 10.1042/BJ20110123

Yang R., Wu R., Mei J., Hu F.R., Lei C.J. Zinc Oxide Nanoparticles Promotes Liver Cancer Cell Apoptosis Through Inducing Autophagy And Promoting P53. Eur Rev Med Pharmacol Sci. 2021;25(3):1557-1563. DOI: 10.26355/Eurrev_202102_24864..
DOI: 10.26355/Eurrev_202102_24864